This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ABSTRACT Atrialflutter (AFL), defined as macro-re-entrant atrial tachycardia, is associated with debilitating symptoms, stroke, heartfailure, and increased mortality. Procedural endpoints include bidirectional conduction block across linear lesions and non-inducibility of atrial tachycardia.
The ECG was interpreted as showing atrialflutter with 2:1 conduction. The heart rate is about 130 bpm. The heart rate could be compatible with that of a 2:1 conducted atrialflutter. Also, lead I could give the initial impression of showing flutter waves. The ECG below was recorded.
Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heartfailure, and may prevent the disease from becoming permanent. Patients are often treated with AADs as frontline therapy for heart rhythm maintenance, though some can experience adverse effects and limited efficacy.
NT-proBNP values less than 300 pg/ml have a 99% negative predictive value for excluding congestive heartfailure. A cutoff of 1200 pg/ml for patients with a normal eGFR is very specific for heartfailure. There is atrial activity before every QRS, but that activity has negative polarity, so it is not sinus rhythm.
Methods The primary effectiveness endpoint (PEE) was 12-month freedom from documented atrial fibrillation/atrialflutter/atrial tachycardia plus freedom from acute procedural failure, nonstudy catheter failure, repeat ablation failure, direct current cardioversion (DCCV), and Class I/III antiarrhythmic drug (AAD) failure.
History of Cardiovascular disease (all studies): Especially any history of heartfailure or structural cardiac disease, including valvular 4. Electrophysiologic studies were performed in selected patients only as clinically appropriate. to 22.7), a history of congestive heartfailure (OR: 5.3, 95% CI = 1.9
ABSTRACT Typical atrialflutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heartfailure, and death.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content